Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

@article{Ekstedt2015FibrosisSI,
  title={Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.},
  author={Mattias Ekstedt and Hannes Hagstr{\"o}m and Patrik Nasr and Mats Fredrikson and Per St{\aa}l and Stergios Kechagias and Rolf W Hultcrantz},
  journal={Hepatology},
  year={2015},
  volume={61 5},
  pages={1547-54}
}
UNLABELLED Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western world, strongly associated with insulin resistance and the metabolic syndrome. Nonalcoholic steatohepatitis, i.e., fatty liver accompanied by necroinflammatory changes, is mostly defined by the NAFLD activity score (NAS). The aim of the current study was to determine disease-specific mortality in NAFLD, and evaluate the NAS and fibrosis stage as prognostic markers for overall and disease-specific… CONTINUE READING
Highly Influential
This paper has highly influenced 13 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Related Discussions
This paper has been referenced on Twitter 13 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 273 extracted citations

Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man

The Journal of clinical endocrinology and metabolism • 2016
View 6 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.

Hepatology research : the official journal of the Japan Society of Hepatology • 2012

Similar Papers

Loading similar papers…